In Reply
- 1 December 2006
- journal article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (34) , 5474-5476
- https://doi.org/10.1200/jco.2006.08.4376
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate DataJournal of Clinical Oncology, 2006
- Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC): Efficacy and safety resultsJournal of Clinical Oncology, 2006
- Randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric (OG) cancer: The REAL 2 trialJournal of Clinical Oncology, 2006
- Randomized phase 3 trial of irinotecan (CPT-11) + 5FU/folinic acid (FA) vs CDDP + 5FU in 1st-line advanced gastric cancer patientsJournal of Clinical Oncology, 2005
- Final results of a randomized controlled phase III trial (TAX 325) comparing docetaxel (T) combined with cisplatin (C) and 5-fluorouracil (F) to CF in patients (pts) with metastatic gastric adenocarcinoma (MGC)Journal of Clinical Oncology, 2005
- Chemotherapy for advanced gastric cancerPublished by Wiley ,2005
- Chemotherapy for advanced gastric cancerPublished by Wiley ,2002
- Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric CancerJournal of Clinical Oncology, 2002
- Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.Journal of Clinical Oncology, 1997
- Large Trials vs Meta-analysis of Smaller TrialsJAMA, 1996